Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.22.1 (
DNase II
)
429
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chromatin from myeloma cells
RPC5
and ABPC22, and from spleen and liver cells of immunized rats and mice, and mice bearing tumours, was fractionated into three part: 0.35 M NaCl-soluble, 2 M NaCl-soluble and residual. The residual fraction from myeloma cells differed from that of immunized spleen cells, described previously as containing unique sequences (5), in that it has higher protein and DNA levels, lower
DNase II
sensitivity and lower template activity.
...
PMID:Differences in salt solubility, DNase II sensitivity and template activity of chromatin from antibody synthesizing spleen cells and myeloma cells RPC 5 and ABPC 22. 689 Jun 25
